What is included with this book?
Contributors | p. ix |
Preface | p. xi |
High-Sensitivity Troponin: A New Tool for Pathophysiological Investigation and Clinical Practice | |
Abstract | p. 2 |
Background and Aim | p. 2 |
Introduction: Troponin Framework Within Myocardial Cells and Release Kinetics After Myocardial Damage | p. 4 |
Impact of the New Definition of Myocardial Infarction on Laboratory Practice and Instrumentation: The Need for High-Sensitivity cTnI and cTnT Methods | p. 5 |
The Impact of High-Sensitivity cTnI and cTnT Methods on Clinical Practice | p. 9 |
High-Sensitivity cTnI and cTnT Methods: A Powerful Tool for Monitoring Physiological Renewal and Pathological Remodeling of the Myocardial Tissue? | p. 19 |
Use of High-Sensitivity cTnI and cTnT Methods in Multimarker Approach for Early Screening: An Increase in Diagnostic and Prognostic Efficiency? | p. 22 |
Conclusion | p. 23 |
References | p. 24 |
Biochemical Biomarkers of Oxidative Collagen Damage | |
Abstract | p. 31 |
The Collagen Family: Structure and Biochemistry | p. 32 |
Chemical Nature and Reactivity of Oxygen | p. 33 |
In Vivo Production of RNOS | p. 35 |
RNOS Biological Activity | p. 37 |
In Vivo Markers of Oxidant Stress | p. 39 |
Oxidant-Induced Changes in Collagens | p. 40 |
Biomarkers of Collagen Oxidative Damage | p. 43 |
Critical Comments and Concluding Remarkers | p. 48 |
References | p. 49 |
Biochemical Basis of Fabry Disease with Emphasis on Mitochondrial Function and Protein Trafficking | |
Abstract | p. 57 |
Introduction | p. 58 |
Inheritance | p. 58 |
Clinical Picture | p. 59 |
Diagnosis | p. 59 |
Treatment | p. 60 |
Biochemical Basis | p. 62 |
References | p. 68 |
Urinary Biomarkers for the Detection of Renal Injury | |
Abstract | p. 73 |
Introduction | p. 74 |
Biomarker Development for Kidney Diseases | p. 75 |
Biomarkers for AKI | p. 81 |
Biomarker Development and Implementation | p. 90 |
Summary | p. 91 |
References | p. 92 |
Biomarkers of Bone and Mineral Metabolism Following Bone Marrow Transplantation | |
Abstract | p. 99 |
Introduction | p. 100 |
Clinical Features of BMT-Related Bone Loss | p. 100 |
Changes in Bone-Turnover Markers After BMT | p. 102 |
Calcium, Parathyroid Hormone (PTH), and Vitamin D | p. 109 |
Sex Hormones | p. 110 |
RANKL and Osteoprotegerin | p. 112 |
Cytokines and Growth Factors | p. 114 |
Conclusion | p. 115 |
References | p. 116 |
Factor V Leiden and Activated Protein C Resistance | |
Abstract | p. 121 |
Introduction | p. 122 |
The Protein C System | p. 123 |
APC Resistance and FV Leiden | p. 130 |
Conclusions and Perspectives | p. 143 |
References | p. 144 |
Self-Assembled Tethered Bimolecular Lipid Membranes | |
Abstract | p. 159 |
Introduction | p. 160 |
Assembly of tBLMs from Telechelics and Reconstitution of Proteins | p. 162 |
The Peptide-Tethered Lipid Bilayer Membrane (peptBLM) | p. 165 |
Protein-Tethered Bilayer Lipid Membrane (protBLM) | p. 170 |
Conclusions | p. 174 |
References | p. 177 |
Index | p. 181 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.